Download PDF
Zeitschrift für Komplementärmedizin 2016; 08(02): 20-24
DOI: 10.1055/s-0036-1581998
Praxis
Anthroposophische Onkologie
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Anthroposophisch-integrative Onkologie – Ein Konzept aus einer Hand

Friedemann Schad
,
Cornelia Herbstreit
Subject Editor:
Further Information

Publication History

Publication Date:
30 March 2016 (online)

    Permissions and Reprints

Summary

Grundanliegen der anthroposophisch-integrativen Onkologie ist die individuelle Begleitung jedes einzelnen Patienten auf dem Boden aller modernen diagnostischen und therapeutischen Verfahren und die Ergänzung der konventionellen Therapieangebote durch ressourcenaktivierende und die Selbstheilungskräfte anregende Zusatztherapien der Anthroposophischen Medizin.

In der wöchentlichen interdisziplinären Tumorkonferenz werden stadiengerechte und leitlinienorientierte Therapiekonzepte empfohlen, besonders großer Wert wird auf Patientenorientierung und individuelle Therapiefindung gelegt. Über alle Krankheitsstadien hinweg werden Zusatztherapien wie Psychoonkologie, Musiktherapie, Maltherapie, Plastizieren, rhythmische Massage, Eurythmietherapie, pflegerische Einreibungen oder Misteltherapie angeboten. Die weitere Betreuung der Patienten kann in unserem Zentrum für ambulante Tumortherapie, bzw. über die etablierte Studienambulanz und Nachsorgedokumentation erfolgen.

Keywords

Anthroposophische Medizin - Brustkrebs - Brustkrebszentrum - multimodale Therapie - Onkologisches Zentrum - Misteltherapie
 

  • Literatur

  • 1 Bradt J, Dileo C et al. Music interventions for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev 2011; 8 (8) CD006911. doi: 10.1002/14651858. CD006911.pub2
    Google Scholar
  • 2 Geue K, Goetze H et al. An overview of art therapy interventions for cancer patients and the results of research. Complementary therapies in medicine 2010; 18 (3) 160-170
    CrossrefGoogle Scholar
  • 3 Girke M. Innere Medizin. Grundlagen und therapeutische Konzepte der Anthroposophischen Medizin. Berlin: Salumed 2010;
    Google Scholar
  • 4 Hack CC, Hüttner N et al. Integrative Medizin in der Gynäkologischen Onkologie – Möglichkeiten und Grenzen Teil 1. Geburtshilfe Frauenheilkd 2013; 73 (10) R63-R80
    Article in Thieme ConnectGoogle Scholar
  • 5 Horneber M, Bueschel G. Mistletoe therapy in oncology. Cochrane Database Syst Rev 2008; (2) CD003297. doi: 10.1002/14651858. CD003297.pub2
    Google Scholar
  • 6 Kienle GS, Albonico HU et al. Anthroposophic medicine: an integrative medical system originating in Europe. Global Advances in Health and Medicine 2013; 2 (6) 20-31
    Google Scholar
  • 7 Kröz M, Büssing A et al. Is mistletoe therapy indicated to reduce cancer-related fatigue and insomnia in cancer patients? – a review. Phytomedicine 2015; 22: S29
    Google Scholar
  • 8 Kröz M, Fink M et al. Multimodal therapy concept and aerobic training in breast cancer patients with chronic cancer-related fatigue. Integrative Cancer Therapies 2013; 12 (4) 301-311
    CrossrefGoogle Scholar
  • 9 Kröz M, Reif M et al. Impact of autonomic and self-regulation on cancer-related fatigue and distress in breast cancer patients – a prospective observational study. Journal of Cancer Survivorship 2013; 1-10
    Google Scholar
  • 10 Kröz M, Schad F et al. Blood and tissue eosino-philia, mistletoe lectin antibodies and quality of life in a breast cancer patient undergoing intratumoral and subcutaneous mistletoe therapy. Forsch Komplementmed Klass Naturheilkd 2002; 9 (3) 160-167
    Google Scholar
  • 11 Mansky PJ, Wallerstedt DB et al. NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors. Evid Based Complement Alternat Med 2013; doi: 10.1155/2013/964592
    Google Scholar
  • 12 Paepke D, Klein E et al. Anthroposophie und Homöopathie in der Integrativen Medizin. Frauenheilkunde up2date 2014; 8 (2) 115-130
    Article in Thieme ConnectGoogle Scholar
  • 13 Piao BK, Wang YX et al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res 2004; 24 (1) 303-309
    Google Scholar
  • 14 Schad F, Axtner J et al. Network Oncology (NO) – a Clinical Cancer Register for Health Services Research and the Evaluation of Integrative Therapeutic Interventions in Anthroposophic Medicine. Forsch Komplementmed 2013; 20 (5) 353-360
    CrossrefGoogle Scholar
  • 15 Schad F, Axtner J et al. Use of integrative therapies in breast cancer patients. Health service research in a network of integrative oncology. Annals of Oncology 2012; 23 (Suppl 9) ix447-ix461
    Google Scholar
  • 16 Schad F, Buchwald D et al. Retrospective analysis of patients with advanced pancreatic cancer under palliative treatment and additive intratumoral application of viscum album L. J Clin Oncol 2011; ASCO Annual Meeting Part 1. 29 (15 Suppl) e14538
    Google Scholar
  • 17 Spiegel D, Kraemer H et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. The Lancet 1989; 334 (8668) 888-891
    CrossrefGoogle Scholar
  • 18 Steele M, Axtner J et al. Adverse and expected drug reactions to therapy with mistletoe extracts (Viscum album L.) in cancer patients. Eur J Cancer 2013;
    Google Scholar
  • 19 Steele ML, Axtner J et al. Safety of intravenous application of Mistletoe (Viscum album L.) preparations in oncology: an observational study. Evid Based Complement Alternat Med 2014; doi: 10.1155/2014/236310
    Google Scholar
  • 20 Steele ML, Axtner J et al. Adverse drug reactions and expected effects to therapy with subcutaneous Mistletoe extracts (Viscum album L.) in cancer patients. Evid Based Complement Alternat Med 2014; doi: 10.1155/2014/724258
    Google Scholar
  • 21 Stumpf C, Bussing A. Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract. Anticancer Drugs 1997; 8 (Suppl 1) S23-26
    Google Scholar